The Saccharomyces cerevisiae [PSI ϩ ] and [URE3] non-Mendelian genetic elements are prions (infectious isoforms) of the Sup35 and Ure2 proteins, respectively (39) . The prion isoforms aggregate in the cytoplasm and propagate by converting the soluble form of the protein into the same misfolded form as it joins the aggregate. Purified Sup35p and Ure2p spontaneously aggregate into amyloid fibers (12, 14, 37) , suggesting that the aggregates in vivo are amyloid in nature and indicating that generation and replication of the amyloid forms of these proteins do not require other cellular factors. Spontaneously arising [PSI ϩ ] or [URE3] clones in cell populations are rare, however, indicating that prion appearance is either hindered by molecular interactions of the native proteins in the cell or actively repressed by cellular processes. Additionally, in vivo propagation of all yeast prions tested is dependent upon Hsp104, a protein chaperone that plays a major role in recovery from stress by solubilizing protein aggregates (26) .
The protein chaperones Hsp104 and Hsp70 both play important roles in the stable propagation of [PSI ϩ ] and [URE3] (2, 13, 23). Hsp104's ability to modify protein conformation has been suggested to aid in inducing structural changes in proteins that could promote propagation of prions (4, 27, 32) . Hsp104 may also break established aggregates into smaller particles that are more efficiently transmitted as prion "seeds" (16, 28) . Overexpressing Hsp104 under growth conditions where it is not normally induced causes [PSI ϩ ] to be lost. Simultaneous overexpression of the HSP70 isoform SSA1 moderates this [PSI ϩ ]-curative effect (24) . Additionally, a specific SSA1 mutation (SSA1-21) causes [PSI ϩ ] to become unstable (13) . HSP104 overexpression does not cure cells of [URE3] (23) , indicating that there is a difference in the nature of the two prions, perhaps reflecting how their replicative forms are recognized as substrates by these chaperones.
Although it is believed to require nucleation, or seeding, what triggers the initial appearance of prions is unknown. Overexpressing the protein determinant of a prion leads to more frequent appearance of the prion, presumably by increasing the number of molecules that can undergo the apparently stochastic change into the prion conformation. The [PIN ϩ ] state (for Psi inducibility), reflecting the capability to be induced to become [PSI ϩ ] by overexpression of Sup35p, was originally shown to be dependent upon a cytoplasmic element and subsequently shown to be conferred by an aggregated prion form of Rnq1p (5, 6 (5) . The mechanism underlying this dependence on heterologous prions for prion induction is unknown. It has been suggested that it may be due to some level of crossseeding of prion polymers or to the sequestration by a resident prion of cellular factors that would otherwise repress generation of heterologous prions (5, 25) . Amyloid propagation is thought to be similar to crystal growth (18) , so negative effects due to interactions of heterologous subunits should also be expected. Here we find negative interactions between prions that may be explained by such a mechanism.
In a Nonsense suppression is expressed as units of ␤-galactosidase (22) . Data are averages and standard deviations of duplicate measurements of at least three cultures from at least two independent experiments. Suppression was measured in 628-4BL transformants with plasmids pUKC815-L and pUKC817-L, which have leader peptides with an in-frame UGG or UAA, respectively, fused to the E. coli ␤-galactosidase gene (35) . Percent readthrough ϭ UAA/UGG ϫ 100.
b Expressed as units of ␤-galactosidase (22) . Data are averages and standard deviations of duplicate measurements of at least three cultures from at least two independent experiments. Activities of DAL5 and SSA1 promoters were determined in 628-4B transformants with plasmids pC2D5 and pDCM74, respectively.
c Data are averages and standard deviations of results from six log-phase 628-4B cultures in YPAD at 30°C. Plasmids. Single-copy (pRS313) and multicopy (pRS423) plasmids have been described previously (33) . Plasmid pH218 (23) , from Herman Edskes (National Institutes of Health), is pRS313 with HSP104. Plasmid pDCM64 is pRS313 with the SSA2 gene at the BamHI site. SSA2 was PCR amplified from strain 628-3A (13) by using primers 5Ј-CGGGATCCCGCCGCTTAAGCGGTGCCCC-3Ј and 5Ј-CGGGATCCCGGTTGACCGGTATCCCCGC-3. Plasmid pDCM65 contains HSP104 under control of the Gal1,10 promoter and was made by ligating the ClaI-SacI fragment from pYSGal104 (19) to pRS423 digested with the same enzymes. Plasmid pDCM66 contains ure2⌬151-158 under control of the Gal1,10 promoter and was made by blunting the ends of the NheI-BglII fragment from pH 377 (9) by using DNA polymerase Klenow fragment (New England Biolabs, Beverly, Mass.) and then ligating it to SmaI-cut pRS423. Plasmid pDCM71 contains SUP35 under control of the Gal1,10 promoter and was made by replacing the BamHI fragment of pDCM66 with a BamHI-digested SUP35 gene spanning nucleotides Ϫ25 to ϩ2219 (where ϩ1 is the A of the translation initiator), which was PCR amplified from strain 628-3A by using primers 5Ј-CCGGATCC ATCTATATCTGCCCACTAG-3Ј and 5Ј-CCGGATCCTTGTTTATGGTATA TGGTAC-3Ј. Plasmid pDCM74 has the Escherichia coli ␤-galactosidase gene under control of the SSA1 promoter and was made by ligating the SalI fragment of pZFO (36) to pRS313 cut with SalI. Plasmid pC2D5, which contains the DAL5 promoter fused to E. coli ␤-galactosidase, was used to monitor Ure2p activity. It was constructed by first destroying the PstI site in the ␤-lactamase gene of plasmid pRR29 (31) by site-directed mutagenesis, creating pRR29-P, and then replacing the XbaI-PstI fragment of pRR29-P with the XbaI-PstI fragment containing HIS3 from pRS423. Plasmids pUKC815-L and pUKC817-L (35), used for measuring nonsense suppression, were gifts from M. Tuite (Canterbury, United Kingdom).
SSA1 was put under control of the strong, constitutive SSA2 promoter by first making NdeI sites at the initiator ATGs of SSA1 on plasmid pJ120 (13) and of SSA2 on pDM64, making pN-1 and pN-2, respectively. The BamHI-NdeI fragment of pN-1, containing the SSA1 promoter, was then replaced by the same fragment from pN-2, containing the SSA2 promoter, creating plasmid pC210. The BamHI-SphI fragment of pC210 was then used to replace the BamHI-SphI fragment of pJ130, creating plasmid pC211. Plasmid pJ130 is pRS313 with SSA1 on the BamHI-ApaI fragment from pJ120.
Assays for [PSI
, an inactive aggregated form of the translation release factor Sup35p, was monitored and its presence was verified as described previously (13) . The presence of [PSI ϩ ] causes nonsense suppression by depleting the cytosol of functional Sup35p. In ade2-1 cells this suppression reduces accumulation of red pigment and confers adenine prototrophy. In [PSI ϩ ] cells, the abundance of active (soluble) Sup35p increases proportionally with temperature (13) , so in some experiments [PSI ϩ ] cells grown on medium lacking adenine were incubated at 25 rather than 30°C. This is a compromise between reducing growth due to the lower temperature and increasing it due to more efficient nonsense suppression of ade2-1, but it aids growth of cells with a weakened [PSI ϩ ] phenotype.
[URE3] was monitored by its ability to allow ura2 mutants to grow on USA selection medium, and its presence was confirmed by its curability when grown in the presence of 3 to 5 mM guanidine hydrochloride. In most instances, verification of [URE3] presence or loss included cytoduction using a representative number of clones. In the experiment described in Table 4 , the difference in loss of [URE3] from [PSI ϩ ] cells with and without induced Hsp104 expression was 4.3 and 7%, respectively. By the Student's t test, there is less than a 7% chance that this difference was due to chance fluctuations alone.
Assays for prion appearance were done as indicated (see Results). For quantitative assays of [URE3] appearance (9) , titers of cultures were determined by plating dilutions onto YPAD, and USA plates with between 50 and 200 colonies were scored after incubation for 4 days at 30°C.
Other methods. Western analyses and cell lysate fractionation assays were performed as indicated or described previously (13) , using cells grown in YPAD to an optical density at 600 nm (OD 600 ) of 0.6 to 1.0. (Table 3 ). This reduction in [PSI ϩ ] appearance was not due to a reduction in induced Sup35p expression as determined by Western analysis (Fig. 4) (Fig. 5 ). An extra copy of the HSP70 isoform SSA2, which has a strong constitutively active promoter and normally produces most of the cytosolic Ssa protein in the cell (10), had no effect on growth of any strain under any condition. An extra copy of HSP104 only affected growth of [ (Fig. 4) (Table 2 ). In a Large inocula of 628-4B cells carrying pDCM65 (galactose-inducible Hsp104) and the indicated prions were taken from plates lacking histidine and grown at 30°C for 2 days to confluent masses of cells on SG (induction) or SD (no induction) plates supplemented with uracil and adenine. Cells from the SD and SG plates were then suspended in water and spread onto YPD plates. The resulting colonies from two independent experiments were scored and verified for prions as indicated in Table 2 molecules that confers prion-forming ability. One suggestion to explain the positive effects that prions have on biogenesis of heterologous prions is that established prion aggregates may, at a frequency much less efficient than that seen for the homologous protein, interact with similar but nonidentical priondetermining domains of heterologous proteins (5) . This would convert the heterologous prion protein into its prion conformation, initiating formation of the heterologous prion.
RESULTS

[PSI
It might be expected that such direct interactions could not only fail to provide the surface necessary for seeding the heterologous prion but also eliminate or reduce the continued growth of resident prion polymers. Indeed, this is believed to be how expression of the PNM2 allele of SUP35 causes loss of [PSI ϩ ] (7, 15). Additionally, [URE3] propagation can be disrupted by overexpressing various Ure2p fragments containing the [URE3] prion-determining domain fused to green fluorescent protein (8) . Various degrees of interference of prion propagation by expression of heterologous prion proteins have also been observed in mammalian cells (29, 30) . In all of these studies, the interacting proteins shared identical or near-identical prion-determining amino acid sequences. Here, we see similar negative effects but between proteins with significantly less identity in their prion-determining regions. Nevertheless, the mutual interference between [URE3] and [PSI ϩ ] prions could be explained if Sup35p and Ure2p interacted with their counterpart prions in an analogous manner.
Another explanation for the positive effects that yeast prions have on the appearance of other prions is that limiting concentrations of cellular factors that normally prevent prion appearance are sequestered by preexisting prions, thus allowing more frequent appearance of heterologous prions (5, 25) . It follows, then, that an excess of such factors would have a negative effect on prion appearance. Obvious candidates for these factors are Hsp104 and Hsp70, protein chaperones known to be involved in yeast prion propagation.
Our data show that Hsp104 and Hsp70 are not independently limiting for prion propagation when [ 
